Mycosis fungoides laboratory findings: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{Cutaneous T cell lymphoma}}
{{Cutaneous T cell lymphoma}}
{{CMG}}; {{AE}} {{AS}}
{{CMG}}; {{AE}} {{AS}}
==Overview==
==Overview==
Laboratory tests for cutaneous T cell lymphoma include [[complete blood count]] (CBC), blood chemistry studies, [[flow cytometry]], [[immunohistochemistry]],  and [[immunophenotyping]].<ref name= seer.cancer> Cutaneous T cell lymphoma. Surveillance, Epidemiology, and End Results . http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52f7/ Accessed on January 19, 2016</ref>
Laboratory tests for cutaneous T cell lymphoma include [[complete blood count]] (CBC), blood chemistry studies, [[flow cytometry]], [[immunohistochemistry]],  and [[immunophenotyping]].<ref name= seer.cancer> Cutaneous T cell lymphoma. Surveillance, Epidemiology, and End Results . http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52f7/ Accessed on January 19, 2016</ref>

Revision as of 20:59, 19 January 2016

Cutaneous T cell lymphoma Microchapters

Home

Patient Information

Overview

Classification

Mycosis fungoides
Sezary syndrome

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Laboratory tests for cutaneous T cell lymphoma include complete blood count (CBC), blood chemistry studies, flow cytometry, immunohistochemistry, and immunophenotyping.[1]

Laboratory tests

Laboratory tests for splenic marginal zone lymphoma include:[1]

References

  1. 1.0 1.1 Cutaneous T cell lymphoma. Surveillance, Epidemiology, and End Results . http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd52f7/ Accessed on January 19, 2016


Template:WikiDoc Sources